Disease management professionals know DM is working. However, measuring disease managementís ROI is no easy task. DM has a way to go before it is accepted as a means to pare down healthcare costs in managed care, according to an exclusive MCIC survey.
How do you prove the ROI value? A new executive briefing audio conference aims to find the answers. Listen in to "How to Prove Disease Management's Value to Managed Care," now on CD ROM
Although measuring return on investment (ROI) is not an exact science, as one consulting firm put it, leading DM authorities point to improved outcomes of plan members with chronic disease, new rare disease programs are being created, and DM providers as well as MCOs are indeed reporting dollars savings.
Three leading DM experts will lead an insightful discussion of measuring the value of DM services during "How to Prove Disease Management's Value to Managed Care." To get answers on proving disease management's worth and how to put those ideas to work, join our expert panel:
Robert Stone, president, Disease Management Association of American,
Alfred Lewis, executive director, Disease Management Purchasing Consortium
George Pfeiffer, president, WorkCare Group, Inc.